You have 9 free searches left this month | for more free features.

Asparaginase

Showing 26 - 50 of 292

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)

Not yet recruiting
  • Lymphoblastic Leukemia
  • Palo Alto, California
    Stanford University
Apr 27, 2023

T-cell Lymphoblastic Lymphoma Trial in Shanghai, Chengdu (Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine,

Not yet recruiting
  • T-cell Lymphoblastic Lymphoma
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin
  • Prednisone,Vincristine, Pegylated-asparaginase, Bortezomib,Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine, methotrexate, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide
  • Shanghai, Shanghai, China
  • +1 more
Dec 27, 2022

Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 2, 2023

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in

Not yet recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +6 more
  • Biopsy
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2022

Acute Lymphoblastic Leukemia Trial in Canada, United States (Doxorubicin, Cytarabine, Methotrexate)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +14 more
Jul 25, 2022

Acute Lymphoblastic Leukemia Trial (GRASPA)

Completed
  • Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 21, 2021

Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Extranodal NK/T-cell Lymphoma Trial in Bangkok (B-MAD chemo)

Active, not recruiting
  • Extranodal NK/T-cell Lymphoma
  • B-MAD chemotherapy
  • Bangkok, Thailand
    King Chulalongkorn Memorial Hospital
May 7, 2022

B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Ph-Like Acute Lymphoblastic Leukemia
  • Duarte, California
    City of Hope Medical Center
Jul 26, 2022

T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • T Acute Lymphoblastic Leukemia
  • T Lymphoblastic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 11, 2023

Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)

Completed
  • Lymphoblastic Lymphoma
  • San Diego, California
  • +1 more
Jun 7, 2022

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Sep 13, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Frankfurt (Main), Germany
    University Hospital of Frankfurt (Main)
Jul 1, 2022

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

Completed
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • asparaginase
  • +15 more
  • Boston, Massachusetts
  • +9 more
Nov 9, 2022

Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

Terminated
  • Acute Lymphocytic Leukemia
  • Adult Lymphoblastic Lymphoma
  • La Jolla, California
  • +3 more
Apr 26, 2022

Acute Myeloid Leukemia Trial in France (GRASPA)

Completed
  • Acute Myeloid Leukemia
  • Nice, Alpes Maritimes, France
  • +20 more
Feb 18, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Canada, United States (asparaginase Erwinia chrysanthemi)

Completed
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • asparaginase Erwinia chrysanthemi
  • Los Angeles, California
  • +21 more
Jun 1, 2021

Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

Completed
  • Acute Lymphoblastic Leukemia
  • San Francisco, California
  • +7 more
Aug 5, 2022

Acute Lymphoblastic Leukemia(ALL)

Completed
  • Acute Lymphoblastic Leukemia
    • Aalborg, Denmark
    • +3 more
    Jan 12, 2021

    Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia Trial in United States (ABT-751, Dexamethasone,

    Terminated
    • Recurrent Pediatric ALL
    • +3 more
    • Los Angeles, California
    • +4 more
    Feb 22, 2021

    NK/T Cell Lymphoma Trial in Singapore (IV Nivolumab, IV Gemcitabine, IV Cisplatin)

    Withdrawn
    • NK/T Cell Lymphoma
    • IV Nivolumab
    • +4 more
    • Singapore, Singapore
      National Cancer Centre Singapore
    Nov 3, 2020

    Acute Lymphoblastic Leukemia Trial in Worldwide (GRASPA)

    Completed
    • Acute Lymphoblastic Leukemia
    • Aarhus, Aarhus C, Denmark
    • +22 more
    Jan 22, 2021

    Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Trial in Shanghai (Anlotinib)

    Completed
    • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
    • Shanghai, China
      Xinhua Hospital
    Sep 13, 2021

    Extranodal NK-T-Cell Lymphoma Trial in Seoul (Etoposide, Ifosfamide, Dexamethasone)

    Unknown status
    • Extranodal NK-T-Cell Lymphoma
    • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    • +1 more
    Oct 21, 2020

    Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer Trial in Worldwide (Daunorubicin, Prednisolone, Vincristine)

    Recruiting
    • Down Syndrome
    • +2 more
    • Shatin, New Territories, Hong Kong
    • +9 more
    Sep 26, 2022